Recent research demonstrates that tumor-intrinsic deficiency of SET domain containing 2, a histone lysine methyltransferase, drives transcriptional reprogramming through aberrant H3K27 acetylation deposition and promotes bone morphogenetic protein 2(BMP2) signaling pathway activation. This evidence concerns the gene BMP2 and neoplasm.